09/08/2026
Diabetic macular edema treatment is continuing to evolve beyond traditional anti-VEGF injections, with research exploring different ways to target the disease and deliver treatment. Read the full article to explore emerging approaches in the DME pipeline and what they could mean for future care: https://brnw.ch/21x5wP6
Wnt modulators, sustained-release TKIs, and topical steroids are in phase 3 trials for DME, offering alternatives to anti-VEGF injections.